The FDA Said No — Now We Need Your Voice
…decision. Share your story with us by filling out this form. Your voice could help drive change for the melanoma…
The FDA Said No — Now We Need Your Voice
…decision. Share your story with us by filling out this form. Your voice could help drive change for the melanoma…
,
,
Living Through TIL Therapy: A Personal Story
…was referred to a dermatologist. Biopsies proved why the spot hadn’t faded with creams: Michael had skin cancer, specifically acral…
,
Fifth Annual Evening in Memory of Valerie Guild
…University of Pennsylvania, and the Director of the Tara Miller Melanoma Center. Mike is Professor and Chair of the Department…
,
“A Celebration of Friendship” Solo Exhibit Shares Heartfelt Story While Raising Funds for AIM at Melanoma Foundation
…show after commission to AIM at Melanoma Foundation. The AIM at Melanoma Foundation (AIM) is the largest non-profit international organization…
,
,
Making the Cut For Melanoma: A Mom’s Motivation
…fundraiser in honor of all melanoma survivors and for those who lost their fight. Traci chose to donate to AIM…
,
,
Sun Safety and Psychological Challenges For Melanoma Survivors
…primarily in adult medicine and oncology with a focus on skin cancers with melanoma, she also serves as a sub-investigator…
,
Replimune Announces Positive Topline Primary Analysis Data by Independent Central Review from IGNYTE Clinical Trial of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma
Replimune Announces Positive Topline Primary Analysis Data by Independent Central Review from IGNYTE Clinical Trial of RP1 plus Nivolumab in…
,
,
Summit of Survival: Tobi’s Journey Beyond Melanoma
In this episode, we are joined by Tobi Sample, a melanoma survivor, to share an extraordinary and inspiring story. Today,…
,
In Plain English: The Keynote 716 Clinical Trial
…(metastatic) melanoma, no drug has been tested in the standard clinical trial format for Stage II melanoma. Qualified patients for…
,
Survivor Spotlight: Brian Halvorson
Melanoma and The Sun By Mara Klecker More than 11,000 students have heard Brian Halvorson tell the story of…
,
Recent Posts
Jun. 05, 2026
Fifth Annual Evening in Memory of Valerie Guild
Jun. 05, 2026
Results for darovasertib in combination with crizotinib in first line HLA*A2:01-negative metastatic uveal melanoma met the study’s primary objective
Jun. 05, 2026
Encouraging results with anzutresgene autoleucel in patients with uveal melanoma and other melanoma subtypes
Jun. 05, 2026
Promising early results with imneskibart, low-dose subcutaneous IL-2, and nivolumab in patients who do not respond to or who relapse after receiving combination checkpoint inhibitors
Jun. 05, 2026